Growth Metrics

Quest Diagnostics (DGX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $7.9 billion.

  • Quest Diagnostics' Total Non-Current Liabilities fell 529.71% to $7.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 billion, marking a year-over-year decrease of 529.71%. This contributed to the annual value of $8.4 billion for FY2024, which is 2348.62% up from last year.
  • Latest data reveals that Quest Diagnostics reported Total Non-Current Liabilities of $7.9 billion as of Q3 2025, which was down 529.71% from $7.8 billion recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Total Non-Current Liabilities peaked at $8.4 billion during Q4 2024, and registered a low of $5.9 billion during Q1 2023.
  • For the 5-year period, Quest Diagnostics' Total Non-Current Liabilities averaged around $6.8 billion, with its median value being $6.3 billion (2021).
  • As far as peak fluctuations go, Quest Diagnostics' Total Non-Current Liabilities tumbled by 832.97% in 2021, and later surged by 3609.44% in 2024.
  • Over the past 5 years, Quest Diagnostics' Total Non-Current Liabilities (Quarter) stood at $6.3 billion in 2021, then dropped by 3.8% to $6.1 billion in 2022, then rose by 11.63% to $6.8 billion in 2023, then increased by 23.49% to $8.4 billion in 2024, then decreased by 5.74% to $7.9 billion in 2025.
  • Its Total Non-Current Liabilities stands at $7.9 billion for Q3 2025, versus $7.8 billion for Q2 2025 and $7.9 billion for Q1 2025.